Route of Administration:
subcutaneous, intramuscular, and intra-articular administration
Current Status:
The product, first used by Indigenous peoples in North America, has been utilized for pain relief in the United States since the 1930s, predating the FDA's establishment. It is a botanical solution made from a single plant and is currently available as a prescription medication in the US market.
Manufacture:
Product is GMP manufactured in the US and currently is a prescription medicine on the US market, treating:
• Sciatic Pain
• Intercostal Neuralgia
• Alchoholic Neuritis
• Occipital Neuralgia
• Brachial Plexus Neuralgia
• Meralgia Paresthetica
• Lumbar Neuralgia
• Trigeminal Neuralgia
Although this product has been safely used daily in the US for over 80 years and is effective in treating various types of pain, there is no preclinical or clinical data available due to its historical use. As a result, there are no formal indications associated with this product.
Investment for Product Equity:
While the product has a long history of safe use for pain relief spanning over 80 years, there are no clinical trials to validate its efficacy. To obtain formal indications for this product, two Phase 3 clinical trials are necessary to demonstrate its effectiveness. The sponsor is currently seeking funding to conduct these trials and is open to offering product equity in return.
Given its long history of daily use, clinical trials to confirm its efficacy are likely to have a high success rate. Following successful clinical trials, we can actively market the product and pursue health insurance coverage for it.
Interested parties can conact us.
Comentarios